Bright Green CorpBGXXQ

時価総額
$17.2万
PER
連邦認可の大麻API製造の新興企業。DEA登録に基づく大麻、抽出物、THCの一括製造を展開。2023年4月のDEA登録取得、2023年5月の輸入登録取得を実施。2024年3月のEB-5私募改定で最大2000万株の発行を計画。ニューメキシコ州で300エーカー×2の土地オプションを保有。
2022年
12月31日
2023年
12月31日
Net loss and comprehensive loss-27,662,077-13,127,648
Change in fair value of voting agreement derivative213,000-
Loss on forfeited deposit (Notes 5, 9, and 16)--970,026
Change in fair value of assets, net (Note 6)-3
Equity in net losses of affiliate135,155218,663
Depreciation704,681638,507
Stock-based compensation194
Prepaid expenses and other assets-90,37940,766
Accounts payable52
Accrued liabilities429,298-36,226
Accrued interest-223,271
Net cash used in operating activities-2,265,770-2,455,612
Deposits1-
Purchase of equity method investment3-
Purchase of property, plant, and equipment113
Net cash used in investing activities-14,368,944-2,533,653
Proceeds from related party line of credit-400,000
Proceeds from issuance of common stock3880,000
Proceeds from issuance of common stock and warrants, issued in private placement, net of issuance costs93
Payments to issuance costs for issuance of common stock and warrants issued in cashless conversion of related party line of credit-10,000
Proceeds from warrants exercised-210,000
Net cash provided by financing activities165
NET DECREASE IN CASH-867,991-404,515
Transfer from due to related party to related party LOC-392,194
Transfer from deposit on equipment to prepaid expenses and other assets-139,617
Related party LOC in exchange for common stock for EB-5 program--880,000
Related party LOC in exchange for common stock and warrants--3,619,789
Adjustment to construction in progress for cancellation of agreement--2,682,000
Due to others for purchase of common stock in Alterola Biotech, Inc.2-